TrialX provides cutting-edge information on new medical treatments and clinical trials in your area.
Meet Dory , your personalized virtual assistant to find clinical trials. Go head, ask her anything. x
All > Massachusetts Investigators

James Butrynski, MD

Dana-Farber Cancer Institute


Boston, Massachusetts - 02115
  • CLINICAL TRIALS 3
  • CONDITIONS13
  • INTERVENTIONS4
  • SINCE2007
Dose-Escalation Study of TH-302 in Combination With Doxorubicin to Treat Patients With Advanced Soft Tissue Sarcoma

August 2008 - August 2010
A Placebo-Controlled Study of Saracatinib (AZD0530) in Patients With Recurrent Osteosarcoma Localized to the Lung

March 2009 - September 2014
Trial of Dasatinib in Advanced Sarcomas

May 2007 - December 2013
Bone Neoplasms

Hemangiopericytoma

Sarcoma

Gastrointestinal Stromal Tumors

Osteosarcoma

Giant Cell Tumors

Rhabdomyosarcoma

Chordoma

Nerve Sheath Neoplasms

Chondrosarcoma

Giant Cell Tumor of Bone

Sarcoma, Alveolar Soft Part

Sarcoma, Ewing's

Placebo

Dasatinib

Saracatinib

Th-302

Related Investigators

Massimo Loda, MD

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute

Suzanne Shusterman

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Childrens Hospital Boston, Dana-Farber Cancer Institute. Children's Hospital Boston

Patrick Y. Wen, MD

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Dana-Farber Cancer Institute Dana Farber / Brigham and Women's Cancer Center Dana-Farber Cancer Institute, Center for Neuro-Oncology Dana-Farber Cancer Instiute

Lewis B. Silverman, MD

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Dana-Farber Cancer Institute and Children's Hospital Dana Faber Cancer Institute, Children's Hospital, Dept. of Pediatric Oncology Children's Hospital Boston Dana-Farber Cancer Institute

Kay Kehoe, Coordinator

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute

Jennifer Brown, MD

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Dana-Farber Cancer Institute

Rachel A. Freedman

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute

Edwin P. Alyea, MD

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Dana-Farber Cancer Institute

F. Stephen Hodi, MD

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Dana-Farber Cancer Institute Dana-Farber Cancer Center

Beth A. Overmoyer, MD, FACP

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute

©2012 Applied Informatics, Inc.
As Seen On:
  • New York Times
  • USA Today
  • bio-itworld logo